echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Risk of overactive bladder linked to dementia drug

    Risk of overactive bladder linked to dementia drug

    • Last Update: 2022-01-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Image: The Rajender R.


    Source: University of Houston

    A study from the University of Houston School of Pharmacy, published in the Journal of the American Academy of Geriatrics, assessed the risk of overactive bladder (OAB), a cholinesterase inhibitor (ChEI) treatment for dementia and Alzheimer's disease side effects of medicines


    Dementia is a group of symptoms associated with a decline in memory, reasoning or other thinking skills


    "The study found that the risk of overactive bladder varies with individual ChEIs," reports the Rajender R.


    Using Medicare data, the study looked at 524,975 Alzheimer's patients (65 years and older) using ChEIs (80.


    While several studies have been conducted to assess the effects of all ChEIs and anti-chlorpyrifos use, few studies have addressed the effects of individual ChEIs on OAB risk


    This research opens a new door


    "The findings suggest a need to understand and manage drug-related morbidity in Alzheimer's patients," Aparasu said


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.